Johnson P - Search Results

1

Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.

Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, Metreweli C, Johnson P, Li AK. Lau WY, et al. Among authors: johnson p. Br J Cancer. 1994 Nov;70(5):994-9. doi: 10.1038/bjc.1994.436. Br J Cancer. 1994. PMID: 7947110 Free PMC article. Clinical Trial.

2

Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma.

Teo PM, Kwan WH, Leung SF, Leung WT, Chan A, Choi P, Yu P, Lee WY, Johnson P. Teo PM, et al. Among authors: johnson p. Br J Radiol. 1996 Mar;69(819):241-8. doi: 10.1259/0007-1285-69-819-241. Br J Radiol. 1996. PMID: 8800868 Clinical Trial.

3

Obstructive jaundice secondary to hepatocellular carcinoma.

Lau WY, Leung KL, Leung TW, Ho S, Chan M, Liew CK, Leung N, Johnson P, Li AK. Lau WY, et al. Among authors: johnson p. Surg Oncol. 1995;4(6):303-8. doi: 10.1016/s0960-7404(10)80042-8. Surg Oncol. 1995. PMID: 8809952

4

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.

Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P. Mok TS, et al. Among authors: johnson p. Cancer. 2001 Jun 15;91(12):2369-77. Cancer. 2001. PMID: 11413527

5

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.

Mok TS, Leung TW, Lee SD, Chao Y, Chan AT, Huang A, Lui MC, Yeo W, Chak K, Johnston A, Johnson P. Mok TS, et al. Among authors: johnson p. Cancer Chemother Pharmacol. 1999;44(4):307-11. doi: 10.1007/s002800050982. Cancer Chemother Pharmacol. 1999. PMID: 10447578 Clinical Trial.

6

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.

Mok TS, Zee B, Chan AT, Yeo W, Yang WT, Yim A, Leung SF, Nguyen B, Leung TW, Johnson P. Mok TS, et al. Among authors: johnson p. Cancer. 2000 Aug 1;89(3):543-50. Cancer. 2000. PMID: 10931453 Clinical Trial.

7

Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.

Seymour MT, Johnson PW, Hall MR, Wrigley PF, Slevin ML. Seymour MT, et al. Among authors: johnson pw. Br J Cancer. 1994 Oct;70(4):719-23. doi: 10.1038/bjc.1994.382. Br J Cancer. 1994. PMID: 7917927 Free PMC article. Clinical Trial.

8

Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.

Mok TS, Steinberg J, Chan AT, Yeo WM, Hui P, Leung TW, Johnson P. Mok TS, et al. Among authors: johnson p. Cancer. 1998 Jun 15;82(12):2439-48. doi: 10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-q. Cancer. 1998. PMID: 9635538

9

A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).

Teo PM, Leung TW, Chan AT, Yu P, Lee WY, Leung SF, Kwan WH, Johnson P. Teo PM, et al. Among authors: johnson p. Eur J Cancer B Oral Oncol. 1995 Nov;31B(6):373-9. doi: 10.1016/0964-1955(95)00026-7. Eur J Cancer B Oral Oncol. 1995. PMID: 8746267

10

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

Woll PJ, Crowther D, Johnson PW, Soukop M, Harper PG, Harris M, Brampton MH, Newlands ES. Woll PJ, et al. Among authors: johnson pw. Br J Cancer. 1995 Jul;72(1):183-4. doi: 10.1038/bjc.1995.299. Br J Cancer. 1995. PMID: 7599050 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,971 results

Search Page

Filters